Reciprocal expression of Slug and Snail in human oral cancer cells

Area of Science:

• Molecular Biology
• Cancer Research
• Oncology

Background:

• Snail (Snai1) and Slug (Snai2) are key regulators of epithelial-mesenchymal transition (EMT).
• These proteins are implicated in cancer progression, drug resistance, and invasion.
• Their specific roles in oral squamous cell carcinoma (OSCC) require further elucidation.

Purpose of the Study:

• To investigate the role of Slug (Snai2) in human oral squamous cell carcinoma (OSCC) cells.
• To determine the combined effects of Snail (Snai1) and Slug (Snai2) in OSCC.
• To explore the potential of targeting Snail and Slug for oral cancer therapy.

Main Methods:

• Utilized small interfering RNA (siRNA) to knockdown Slug and Snail expression in OSCC cells.
• Assessed the impact of siRNA on anti-tumor drug resistance and invasive properties.
• Investigated the effects of transforming growth factor (TGF)-β on Snail and Slug expression.

Main Results:

• Slug is highly expressed in OSCC cells, and its knockdown reduces drug resistance and invasion.
• TGF-β upregulates both Snail and Slug, enhancing drug resistance in OSCC.
• Knockdown of either Snail or Slug individually partially mitigates malignant phenotypes; combined knockdown dramatically suppresses them.

Conclusions:

• Slug and Snail act in tandem to promote malignant phenotypes in oral cancer.
• Targeting both Slug and Snail simultaneously is a promising therapeutic strategy for oral cancer.
• Nucleic acid medicines targeting Slug and Snail represent a potential treatment for oral cancer.